|
Q3 FY2026
As of Jul 31, 2026
|
Q2 FY2026
As of Apr 30, 2026
|
Q1 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Oct 31, 2025
|
Q3 FY2025
As of Jul 31, 2025
|
Q2 FY2025
As of Apr 30, 2025
|
Q1 FY2025
As of Jan 31, 2025
|
Q4 FY2024
As of Oct 31, 2024
|
Q3 FY2024
As of Jul 31, 2024
|
Q2 FY2024
As of Apr 30, 2024
|
Q1 FY2024
As of Jan 31, 2024
|
Q4 FY2023
As of Oct 31, 2023
|
Q3 FY2023
As of Jul 31, 2023
|
Q2 FY2023
As of Apr 30, 2023
|
Q1 FY2023
As of Jan 31, 2023
|
Q4 FY2022
As of Oct 31, 2022
|
Q3 FY2022
As of Jul 31, 2022
|
Q2 FY2022
As of Apr 30, 2022
|
Q1 FY2022
As of Jan 31, 2022
|
Q4 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Cultural costs | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Receivables/other from related parties, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Real estate development | ||||||||||||||||||||
| Equity in investments | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Convertible Preferred Stock and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Growers and suppliers payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Payables to related parties | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt, less current portion | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Convertible preferred stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series B-2 Convertible Preferred Stock | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Series A Junior Participating Preferred Stock – $0.01 par value (20,000 shares authorized: zero issued or outstanding at July 31, 2026 and October 31, 2025) | ||||||||||||||||||||
| Series A Junior Participating Preferred Stock | ||||||||||||||||||||
| Total series A Junior Participating Preferred Stock – $0.01 par value (20,000 shares authorized: zero issued or outstanding at July 31, 2026 and October 31, 2025) | ||||||||||||||||||||
| Common Stock – $0.01 par value (39,000,000 shares authorized: 18,382,984 and 18,287,868 shares issued and 18,132,007 and 18,036,891 shares outstanding at July 31, 2026 and October 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 250,977 shares at July 31, 2026 and October 31, 2025 | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities, convertible preferred stock and stockholders’ equity | ||||||||||||||||||||
| Convertible preferred stock, shares outstanding (in shares) | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series B-2 Convertible Preferred Stock | ||||||||||||||||||||
| Convertible preferred stock, shares issued (in shares) | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series B-2 Convertible Preferred Stock | ||||||||||||||||||||
Loading...
